首页 | 本学科首页   官方微博 | 高级检索  
     

趋化因子受体CCR7及CXCR4在结肠癌组织中的表达及意义
引用本文:姜文营,张建良,纪志鹏,傅勤烨,周勇,丁印鲁. 趋化因子受体CCR7及CXCR4在结肠癌组织中的表达及意义[J]. 中国现代普通外科进展, 2009, 12(7): 561-564
作者姓名:姜文营  张建良  纪志鹏  傅勤烨  周勇  丁印鲁
作者单位:山东大学第二医院,普通外科,山东,济南,250033
摘    要:目的:观察趋化因子受体CCR7及CXCR4在结肠癌组织中的表达及与临床病理特征的关系,探讨其评价结肠癌侵袭转移及预后的意义.方法:对110例行结肠癌根治术的结肠癌组织标本采用免疫组织化学方法检测CCR7及CXCR4的表达.结果:CCR7、CXCR4在110例结肠癌组织中阳性表达率分别为59.1%和45.5%,其中淋巴结转移组表达率分别为90.8%、69.2%,无淋巴结转移组表达率分别为13.3%、11.1%,差异有统计学意义(P<0.05).CCR7及CXCR4的表达与结肠癌浸润深度、淋巴结转移、肿瘤分期密切相关(P<0.05),与年龄、性别、肿瘤大小、组织学类型及分化程度无关(P>0.05).CCR7判断结肠癌淋巴结转移的敏感性、特异性、阳性预测值及阴性预测值分别为90.8%、86.7%、90.8%、86.7%;CXCR4判断结肠癌淋巴结转移的敏感性、特异性、阳性预测值及阴性预测值分别为69.2%、88.9%、90.O%、66.7%;联合检测CCR7及CXCR4诊断结肠癌淋巴结转移的准确率为88.1%.结论:趋化因子受体CCR7及CXCR4与结肠癌淋巴结转移密切相关,联合检测CCR7及CXCR4对预测结肠癌淋巴结转移情况、评价预后、判定术后治疗方案具有指导价值.

关 键 词:受体  趋化因子  结肠肿瘤  淋巴  转移

Expression of chemokine receptor CCR7 and CXCR4 in human colorectal carcinoma and its significance
JIANG Wen-ying,ZHANG Jian-liang,JI Zhi-peng,FU Qin-ye,ZHOU Yong,DING Yin-lu. Expression of chemokine receptor CCR7 and CXCR4 in human colorectal carcinoma and its significance[J]. Chinese Journal of Current Advances in General Surgery, 2009, 12(7): 561-564
Authors:JIANG Wen-ying  ZHANG Jian-liang  JI Zhi-peng  FU Qin-ye  ZHOU Yong  DING Yin-lu
Affiliation:Jinan 250033;China
Abstract:Objective:To observe the expression of chemokine receptor CCR7 and CXCR4 in human colorectal carcinoma and its significance,so as to assess their expression with the metastasis and prognosis of colorectal carcinoma. Methods:Immunohistochemistry was used to detect the expression of chemokine receptor CCR7 and CXCR4 in 110 patients with colon cancer.The relationship between the CCR7 and CXCR4 expression and the clinic pathological characters was statistically analyzed. Results:CCR7 and CXCR4 expression were p...
Keywords:
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号